- Patent Title: Sodium channel protein Nav1.4-targeting polypeptide and use thereof
-
Application No.: US17329194Application Date: 2021-05-25
-
Publication No.: US11548918B2Publication Date: 2023-01-10
- Inventor: Mengru Chen
- Applicant: Mengru Chen
- Applicant Address: CN Guangzhou
- Assignee: Mengru Chen
- Current Assignee: Mengru Chen
- Current Assignee Address: CN Guangzhou
- Agency: Bayramoglu Law Offices LLC
- Priority: CN202110129660.X 20210129
- Main IPC: C07K14/00
- IPC: C07K14/00 ; A61P17/00 ; A61K38/00

Abstract:
A sodium channel protein Nav1.4-targeting polypeptide is disclosed, which has an amino acid sequence of SEQ ID NO:1. The polypeptide includes a first disulfide bond between Cys-3 and Cys-17, a second disulfide bond between Cys-4 and Cys-23, and a third disulfide bond between Cys-12 and Cys-24. The polypeptide has a complex coiled structure consisting of a main chain and disulfide bonds, in which three key residues LYS10, ARG18, and ARG22 could interact with Nav1.4 and be essential to block its penetrability of sodium. The polypeptide can target sodium channel protein Nav1.4 to form a stable protein complex; compared with naturally extracted drugs, the polypeptide Nav1.4 is superior in terms of yield, production, and cost saving, making it a promising Nav-targeting drug with broad application prospects.
Public/Granted literature
- US20220242915A1 SODIUM CHANNEL PROTEIN NAV1.4-TARGETING POLYPEPTIDE AND USE THEREOF Public/Granted day:2022-08-04
Information query